Sigilon Therapeutics seeks to develop functional cures for patients with a broad range of acute and chronic diseases by harnessing the power of the human cell through its Shielded Living Therapeutics™ platform. Sigilon’s product candidates are non-viral engineered cell-based therapies designed to restore functions or provide therapeutic molecules needed by patients living with acute or chronic diseases such as diabetes and...
Sigilon Therapeutics seeks to develop functional cures for patients with a broad range of acute and chronic diseases by harnessing the power of the human cell through its Shielded Living Therapeutics™ platform. Sigilon’s product candidates are non-viral engineered cell-based therapies designed to restore functions or provide therapeutic molecules needed by patients living with acute or chronic diseases such as diabetes and lysosomal diseases.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.